Skip to main content
. 2019 Nov 16;24(Suppl 1):92–102. doi: 10.1007/s10157-019-01817-3

Table 2.

PK parameters of dotinurad in plasma and urine on days 1 and 7 in the overproduction, underexcretion, and combination groups

Parameters Treatment groups
Overproduction (n = 6) Underexcretion (n = 6) Combination (n = 6)
Cmax (ng/mL)
 Day 1 78.68 ± 14.92 83.80 ± 9.77 83.28 ± 10.22
 Day 7 102.90 ± 21.43 101.20 ± 18.28 108.33 ± 15.49
Tmax (h)
 Day 1 3.50 ± 0.55 4.00 ± 0.00 3.17 ± 0.41
 Day 7 3.67 ± 0.52 3.17 ± 0.98 3.67 ± 0.52
T1/2 (h)
 Day 1 11.67 ± 1.92 10.24 ± 1.32 11.37 ± 2.23
 Day 7 11.49 ± 1.49 10.44 ± 0.66 10.83 ± 0.96
AUC0-inf (ng h/mL)
 Day 1 1277.29 ± 490.68 1224.51 ± 197.78 1274.93 ± 155.18
 Day 7 1688.49 ± 633.70 1561.90 ± 257.42 1688.15 ± 354.21
Cltot/F (L/h)
 Day 1 0.86 ± 0.24 0.83 ± 0.14 0.79 ± 0.61
 Day 7 0.64 ± 0.17 0.66 ± 0.11 0.61 ± 0.13
kel (1/h)
 Day 1 0.0608 ± 0.0101 0.0686 ± 0.0089 0.0627 ± 0.0104
 Day 7 0.0611 ± 0.0071 0.0666 ± 0.0043 0.0644 ± 0.0051
Vd/F (L)
 Day 1 13.93 ± 2.59 12.14 ± 0.82 12.84 ± 1.64
 Day 7 10.39 ± 1.94 9.81 ± 1.27 9.52 ± 1.75
MRT0-inf (h)
 Day 1 17.68 ± 3.02 15.74 ± 2.00 16.77 ± 3.38
 Day 7 16.78 ± 2.23 14.88 ± 1.09 15.53 ± 1.63

Data are presented as mean ± SD